1341 |
Moderators\' Introductory Keynote: Invasive vs Non-invasive FFR |
Nico Pijls |
Apr. 08. 22 |
1340 |
FFR-Guided PCI for Multivessel CAD in 2022 |
William F. Fearon |
Apr. 08. 22 |
1339 |
Moderators\' Introductory Keynote: Revascularization after FAME 3- How Will We Decide? |
Spencer B. King III |
Apr. 08. 22 |
1338 |
Racial Disparities in TAVR: Similarities and Differences |
Duk-Woo Park |
Apr. 08. 22 |
1337 |
The UPSTREAM Management of Aortic Stenosis |
Martin Bert Leon |
Apr. 08. 22 |
1336 |
CABG Helps People Live Longer |
S. Christopher Malaisrie |
Apr. 08. 22 |
1335 |
Which Patients with Stable CAD Benefit from PCI in the Post-ISCHEMIA Era? |
Gregg W. Stone |
Apr. 08. 22 |
1334 |
OMT Is Always the Default Choice |
David J. Maron |
Apr. 08. 22 |
1333 |
Lower for Longer: Effective Lipid Lowering – Rising on Ezetimibe Therapy |
Gyu-Chul Oh |
Apr. 08. 22 |
1332 |
Early for Longer: Intensive Lipid Lowering - Moving Beyond Statins Alone |
Dong-Bin Kim |
Apr. 08. 22 |